Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.70
-0.02-0.74%
At close: Sep 18, 5:00 PM EST
$2.75
0.051.85%
After Hours: 7:50 PM EST
Editas Medicine Inc (EDIT) Stock Price, Quote, News & History
EDITNASDAQ
Editas Medicine (EDIT) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Editas Medicine (EDIT) stock?
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Who are Editas Medicine (EDIT) competitors?
Other companies in Editas Medicine’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Editas Medicine (EDIT) stock?
Editas Medicine has a consensus price target of $6.75.
What is the current price for Editas Medicine (EDIT)?
The stock price for Editas Medicine (NASDAQ: EDIT) is $2.75 last updated September 18, 2026 at 7:50 PM EDT.
Does Editas Medicine (EDIT) pay a dividend?
There are no upcoming dividends for Editas Medicine.
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
Editas Medicine does not have any upcoming earnings scheduled.
Is Editas Medicine (EDIT) going to split?
There is no upcoming split for Editas Medicine.
What sector and industry does Editas Medicine (EDIT) operate in?
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
